GURU.Markets stock price, segment price, and overall market index valuation
The company's share price iRhythm Technologies
iRhythm Technologies produces wearable devices for long-term heart rate monitoring. Its stock price is highly volatile and depends on reimbursement rates from public and private insurers, which is a key factor in its business model.
Share prices of companies in the market segment - Heart
iRhythm is a company that produces the Zio wearable device for long-term heart rate monitoring. We classify it in the Heart sector. The chart below shows the overall performance of this medical technology segment, not just iRhythm stock.
Broad Market Index - GURU.Markets
iRhythm Technologies is a digital health company that developed the Zio wearable patch for long-term heart rate monitoring. As an innovator in cardiology, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with iRhythm's performance to assess the prospects for the telemedicine sector.
Change in the price of a company, segment, and market as a whole per day
IRTC - Daily change in the company's share price iRhythm Technologies
The daily price change of iRhythm Technologies (IRTC), a developer of wearable cardiac monitoring devices, reflects its sensitivity to medical reimbursement, clinical data, and competition. IRTC's volatility is a measure specific to the medical technology sector. IRTC's Change_Co is important for formula analysis of assets at the intersection of medicine and electronics.
Daily change in the price of a set of shares in a market segment - Heart
The medical technology sector in which iRhythm Technologies operates is highly dynamic. This chart reflects the industry's average volatility. It serves as a benchmark for assessing how sensitive iRhythm's cardiac monitoring business is to insurance rates and competition.
Daily change in the price of a broad market stock, index - GURU.Markets
iRhythm Technologies is a leader in wearable devices for long-term heart rate monitoring. The medical technology market is growing rapidly. The chart below shows the volatility in this sector, helping to assess how iRhythm shares respond to innovation and competition.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization iRhythm Technologies
iRhythm is a leader in wearable devices for long-term cardiac monitoring. Its year-over-year performance reflects its rapid growth and the adoption of its technology in clinical practice. The chart below tells the story of this medical technology leader.
Annual dynamics of market capitalization of the market segment - Heart
iRhythm Technologies, Inc. is a leader in long-term heart rate monitoring with its Zio wearable devices. Its technology is changing approaches to arrhythmia diagnostics. The chart below shows how its innovations and the fight for adequate reimbursement from insurance companies are impacting its performance in the sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
iRhythm Technologies, with its wearable heart monitoring devices, is a growth story in the medical technology sector. Its stock performance is driven by the speed of adoption by doctors and the insurance system, not by the state of the economy. The chart reflects the potential of this disruptive technology in the vast cardiology market.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization iRhythm Technologies
The market capitalization of iRhythm, a heart rate monitoring company, depends on its procedure volume. The monthly fluctuations in the chart reflect the number of patients using its Zio devices, as well as changes in reimbursement rates from public and private insurers, which directly impact its revenue.
Monthly dynamics of market capitalization of the market segment - Heart
This chart illustrates the dynamics of the medical technology sector, particularly in cardiology. For iRhythm, a leader in remote cardiac monitoring, this provides context. Its movements reflect the adoption rate of its Zio patches and changes in reimbursement rates.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
iRhythm Technologies, Inc. is a digital health company providing wearable devices for diagnosing cardiac arrhythmias. Demand for its services is driven by medical needs. The broader market graph serves as a backdrop to assess how its innovative technology and growing acceptance by physicians and insurers have enabled its growth trajectory.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization iRhythm Technologies
iRhythm Technologies specializes in heart rate monitoring. Its weekly stock price fluctuates extremely sensitively to news from the medical regulatory landscape. Changes in Medicare reimbursement rates or the emergence of competitors can cause sharp movements. This chart shows the volatility of this innovative medical technology company.
Weekly dynamics of market capitalization of the market segment - Heart
iRhythm Technologies operates in the medical technology sector, which is often sensitive to broader news surrounding the Medicare reimbursement system. Changes in reimbursement rates can impact the entire industry. This chart shows how the company is positioned in the context of these sectoral risks.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
iRhythm Technologies operates in the medical diagnostics sector, which should make it less dependent on economic cycles. The chart will show how insulated the company's shares are from general market fluctuations. Do they follow technology and insurance payout news, ignoring macro noise?
Market capitalization of the company, segment and market as a whole
IRTC - Market capitalization of the company iRhythm Technologies
The iRhythm Technologies chart shows the market's valuation of innovations in cardiac diagnostics. Its market capitalization is a bet that wearable cardiac monitoring devices will replace traditional methods. The dynamics reflect news about clinical data, insurance company decisions, and competition.
IRTC - Share of the company's market capitalization iRhythm Technologies within the market segment - Heart
iRhythm Technologies is a pioneer in long-term heart rate monitoring using wearable devices. Its share of the cardiac equipment market capitalization reflects its leadership and innovation. The chart below shows how the adoption of its technology in clinical practice and insurance company decisions determine its market share in the medical technology market.
Market capitalization of the market segment - Heart
iRhythm Technologies has developed a wearable patch for long-term heart rate monitoring. How big is the cardiac innovation arena? The graph below shows the total market capitalization of the sector. Its growth reflects the enormous need for early detection of arrhythmias and stroke prevention.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart shows how the market values innovations in cardiac diagnostics. The market capitalization of iRhythm Technologies, the creator of wearable ECG monitors, depends on the number of patients using their devices and the decisions of insurance companies. It's a visual representation of the battle for a new standard in cardiology, where data accuracy determines market share.
Book value capitalization of the company, segment and market as a whole
IRTC - Book value capitalization of the company iRhythm Technologies
iRhythm Technologies' assets include its wearable cardiac monitor production lines and R&D laboratories. Its book value reflects the value of this high-tech equipment and infrastructure. The chart below shows how the company has invested in its physical assets to advance cardiac diagnostics.
IRTC - Share of the company's book capitalization iRhythm Technologies within the market segment - Heart
iRhythm Technologies' strength lies in its cutting-edge manufacturing and research centers. Here, data from wearable biosensors for cardiac diagnostics is generated and analyzed. These physical facilities are the health factories of the future. The graph below shows the company's share of the high-tech medical infrastructure in its segment.
Market segment balance sheet capitalization - Heart
iRhythm Technologies provides diagnostic services using its devices but does not own large manufacturing facilities. Its business is less capital-intensive than that of heavy medical equipment manufacturers. The chart below illustrates the scale of the sector, allowing one to evaluate its asset-light model.
Book value of all companies included in the broad market index - GURU.Markets
iRhythm Technologies produces wearable cardiac monitoring devices. Its book value may be small compared to the market, but it represents a manufacturing base for innovative technologies. This stake in BCap_All is the material resource behind saving lives through early detection.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - iRhythm Technologies
iRhythm's balance sheet is the value of the equipment used to manufacture its wearable ECG monitors. Its market capitalization is a valuation of its unique technology and data-driven business model. Its high P/B indicates that the market sees value not in the hardware, but in the company's ability to transform the approach to arrhythmia diagnostics.
Market to book capitalization ratio in a market segment - Heart
iRhythm Technologies offers wearable heart rate monitoring devices. The company's value lies in its technology, data, and contracts with healthcare providers, not in physical assets. The chart illustrates the high premium investors pay for innovation and leadership in the cardiac monitoring market.
Market to book capitalization ratio for the market as a whole
iRhythm Technologies specializes in developing wearable heart rate monitoring devices to aid in the diagnosis of arrhythmias. Compared to average market valuations shown in the chart, its high premium reflects the innovativeness of its technology, its large potential market, and its healthcare-focused model.
Debts of the company, segment and market as a whole
IRTC - Company debts iRhythm Technologies
iRhythm Technologies, a digital health company, is using debt capital to scale its business. The funds are being used to refine its wearable heart monitoring devices, expand its sales team, and secure insurance approvals. The debt load reflects aggressive investments to capture share in a rapidly growing market.
Market segment debts - Heart
iRhythm Technologies develops wearable devices for diagnosing cardiac arrhythmias. This is a rapidly growing market at the intersection of medicine and technology. The company is actively investing in R&D to improve its sensors and algorithms, as well as in marketing. This chart shows whether the company is using debt to finance its technological advancement and expansion.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio iRhythm Technologies
iRhythm Technologies specializes in wearable heart rate monitoring devices. Like many companies in the medtech sector, it actively invests in research, development, and market entry. This chart shows how iRhythm relies on debt financing to scale its business and compete in a rapidly growing sector.
Market segment debt to market segment book capitalization - Heart
iRhythm Technologies specializes in wearable heart rate monitoring devices. This chart reflects the overall debt load in the medical technology and cardiology sector. It helps understand how companies finance innovation and clinical trials, and how iRhythm manages its capital to scale its business in a competitive environment.
Debt to book value of all companies in the market
iRhythm Technologies operates in the fast-growing digital healthcare sector. This chart shows the overall debt level in the market, reflecting the availability of capital for growth. For iRhythm, this indicates the ease of funding innovation and expansion, given the general willingness of investors and lenders to support growing companies.
P/E of the company, segment and market as a whole
P/E - iRhythm Technologies
iRhythm Technologies develops wearable heart rate monitoring devices to aid in the diagnosis of arrhythmia. This chart shows the high valuation investors place on this company, which is pioneering medical diagnostics. The stock price premium reflects expectations of widespread adoption of its technology and future revenue growth.
P/E of the market segment - Heart
The digital medicine sector, where iRhythm Technologies is an innovator, attracts investors with its high growth potential. This chart shows the average valuation for medical device companies. It helps understand the premium the market is willing to pay for iRhythm's breakthrough cardiac monitoring technology compared to traditional solutions.
P/E of the market as a whole
iRhythm Technologies has developed a wearable device (Zio patch) for long-term heart rate monitoring. The company's growth depends on physician adoption of its technology and insurance coverage. Its valuation is determined not by the general economic cycles reflected in this chart, but by the specifics of the healthcare system and the proven effectiveness of its product.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company iRhythm Technologies
iRhythm Technologies specializes in wearable heart rate monitoring devices. The company's future profitability depends on the widespread adoption of its technology by doctors and patients, as well as insurance reimbursement policies. This chart reflects analysts' forecasts for cardiac monitoring market growth and iRhythm's ability to strengthen its position.
%20P%2FE%20iRhythm%20Technologies&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-iRhythm-Technologies&v=1772578224341 "Chart of the company's future (projected) P/E iRhythm Technologies")
Future (projected) P/E of the market segment - Heart
iRhythm Technologies has developed the Zio wearable device for long-term heart rate monitoring, which helps detect arrhythmias. This chart compares the company's revenue forecasts with the average for the medical technology sector. It helps understand whether the market is pricing in a premium for its innovative product and its potential to displace traditional diagnostic methods.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Heart&v=1772578224360 "Future (projected) P/E graph of the market segment - Heart")
Future (projected) P/E of the market as a whole
iRhythm Technologies has developed a wearable device for long-term heart rate monitoring. This chart reflects the overall investment environment. For iRhythm, as an innovative medical company, the overall economic climate is less important than the speed of adoption of its technology by doctors and patients, as well as insurance companies' coverage decisions.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772578224363 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit iRhythm Technologies
iRhythm Technologies has developed a wearable device for long-term heart rate monitoring. This chart shows the financial history of the company, which is innovating in cardiac diagnostics. Its profitability depends on the number of patients using its devices and the level of reimbursement from insurance companies.
Profit of companies in the market segment - Heart
iRhythm Technologies developed the Zio wearable device for long-term heart rate monitoring, which helps diagnose arrhythmia. The company is a pioneer in digital cardiology. This chart shows the overall profitability of the cardiac equipment sector, reflecting the adoption of new technologies and the level of healthcare spending.
Overall market profit
iRhythm Technologies offers solutions for long-term heart rate monitoring. Like many companies in the medical technology sector, its business is immune to economic downturns. The need for arrhythmia diagnostics is independent of the business cycle. Stable demand from the healthcare system makes iRhythm resilient to the volatility visible on the chart.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company iRhythm Technologies
iRhythm Technologies has developed an innovative wearable sensor, Zio, for long-term heart rate monitoring, which helps detect arrhythmias. Future revenue expectations reflected here depend on the widespread adoption of this technology by physicians and insurance companies' reimbursement policies.
%20profit%20of%20the%20company%20iRhythm%20Technologies&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-iRhythm-Technologies&v=1772578224457 "Graph of future (projected) profit of the company iRhythm Technologies")
Future (predicted) profit of companies in the market segment - Heart
iRhythm Technologies has revolutionized arrhythmia diagnostics with its Zio wearable patch, which continuously monitors heart rhythm. This graph illustrates expectations for the medical technology sector. iRhythm's success depends on broad insurance coverage and physician confidence in the superiority of its technology over traditional methods, opening a huge market.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Heart&v=1772578224494 "Graph of future (predicted) profits of companies in a market segment - Heart")
Future (predicted) profit of the market as a whole
iRhythm Technologies offers solutions for long-term heart rate monitoring. The company's business operates at the intersection of healthcare and technology. While demand for medical services is stable, the implementation of new technologies depends on clinic budgets. The total revenue forecast in this chart indirectly indicates the healthcare system's financial capacity to invest in innovation.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772578224645 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - iRhythm Technologies
iRhythm Technologies has developed a wearable device for long-term heart rate monitoring. This figure demonstrates the high valuation investors place on its revenue, anticipating widespread adoption of its technology in cardiology. The chart reflects confidence in the product's revolutionary potential and the growth of the digital medicine market.
P/S market segment - Heart
iRhythm Technologies has developed a wearable device for long-term heart rate monitoring, aiding in the diagnosis of arrhythmias. The company's revenue growth is driven by the adoption of its technology in medical practice. This chart shows how the market values companies in the medical technology sector, helping to understand whether it views iRhythm as a leader in its niche.
P/S of the market as a whole
iRhythm Technologies has developed the Zio wearable device for long-term heart rate monitoring, helping diagnose arrhythmias. It's an innovative product in digital medicine. This indicator shows the premium investors are willing to pay for the revenue of a company that is changing approaches to diagnostics and has enormous growth potential.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company iRhythm Technologies
iRhythm Technologies specializes in wearable heart rate monitoring devices, helping diagnose arrhythmia. This chart shows how the market estimates the company's future revenue. It reflects expectations regarding the rate of adoption of its technology by doctors and patients, as well as reimbursement policies from insurance companies.
%20P%2FS%20iRhythm%20Technologies&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-iRhythm-Technologies&v=1772578224871 "The graph of the company's future (projected) P/S iRhythm Technologies")
Future (projected) P/S of the market segment - Heart
iRhythm Technologies offers wearable devices for long-term heart rate monitoring, aiding in the diagnosis of arrhythmias. This chart compares the company's estimated future revenue with the medical technology sector. It illustrates the extent to which investors believe in the superiority of iRhythm's technology and its ability to replace traditional diagnostic methods.
%20P%2FS%20market%20segment%20graph%20-%20Heart&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Heart&v=1772578224922 "Future (projected) P/S market segment graph - Heart")
Future (projected) P/S of the market as a whole
iRhythm Technologies specializes in wearable heart rate monitoring devices, aiding in the diagnosis of arrhythmias. The optimism reflected in this chart is fueled by innovations in digital health. iRhythm's solutions are changing approaches to cardiology, and the company's growth demonstrates how technology can improve treatment outcomes and create new markets in medicine.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772578224953 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales iRhythm Technologies
iRhythm Technologies specializes in diagnosing cardiac arrhythmias using its wearable biosensor, Zio. The company's revenue, shown in this chart, is generated by providing heart rhythm monitoring services. The growth reflects the growing number of patients using this advanced diagnostic technology.
Sales of companies in the market segment - Heart
iRhythm Technologies has revolutionized cardiac arrhythmia diagnostics with its wearable biosensor, Zio. The company's growth reflects the shift toward digital and remote healthcare. This chart illustrates the dynamics of the medical technology market, where iRhythm's innovative approach to cardiac monitoring is changing the standards of cardiac care and shaping a new segment.
Overall market sales
iRhythm Technologies, a pioneer in long-term heart rate monitoring, relies on innovation in healthcare. The growth in overall economic activity, reflected in this chart, is boosting hospital and insurance company budgets. This allows them to more actively implement advanced technologies, such as iRhythm wearables, to improve diagnostics.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company iRhythm Technologies
iRhythm Technologies has developed a cutting-edge system for remote heart rate monitoring using the Zio wearable biosensor. The company's revenue forecast reflects the rapid adoption of telemedicine and digital diagnostics. It also shows analysts' expectations for the number of Zio prescriptions by doctors for arrhythmia detection, a key growth driver.
%20sales%20of%20the%20company%20iRhythm%20Technologies&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-iRhythm-Technologies&v=1772578225091 "Schedule of future (projected) sales of the company iRhythm Technologies")
Future (projected) sales of companies in the market segment - Heart
iRhythm Technologies has developed an innovative system for long-term heart rate monitoring using the Zio wearable biosensor. This facilitates the early diagnosis of arrhythmias. This chart shows forecasts for the cardiac equipment sector, allowing one to assess how iRhythm technologies are changing approaches to diagnostics and influencing market growth.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Heart&v=1772578225134 "Schedule of future (projected) sales of companies in the market segment - Heart")
Future (projected) sales of the market as a whole
iRhythm Technologies, a developer of wearable heart monitoring devices, sees this chart as an indicator of access to healthcare. The overall improvement in the economic situation reflected here means more people have insurance and can afford advanced diagnostic solutions. This expands the potential market for the company's products.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772578225143 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality iRhythm Technologies
iRhythm Technologies specializes in wearable heart rate monitoring devices. The company operates at the intersection of medicine and technology, offering arrhythmia diagnostic services. This chart demonstrates the profitability of its business model, which combines device sales and data analysis. It reflects the company's ability to convert revenue from its innovative solutions into profit.
Market segment marginality - Heart
iRhythm Technologies is a digital health company specializing in wearable heart rate monitoring devices, such as the Zio patch. The data presented compares its profitability with other companies in the medical technology sector. Outperformance may indicate the product's technological leadership and widespread acceptance by physicians and insurance companies.
Market marginality as a whole
iRhythm Technologies has developed a wearable device for long-term heart rate monitoring, changing the approach to diagnostics. Based on its overall profitability, iRhythm represents the disruptive medical technology sector. Their profitability depends on the widespread adoption of their devices by physicians and the level of insurance coverage.
Employees in the company, segment and market as a whole
Number of employees in the company iRhythm Technologies
iRhythm Technologies has developed an innovative solution for long-term heart rate monitoring. This chart shows the growth of the team analyzing data and promoting the technology to physicians. The staff increase is directly related to the speed of adoption of their platform in medical practice and the growing number of patients.
Share of the company's employees iRhythm Technologies within the market segment - Heart
iRhythm Technologies has created a revolutionary system for long-term heart rate monitoring. Behind this technology is a team of engineers, data analysts, and clinicians. This chart shows the percentage of cardiac diagnostic specialists iRhythm attracts, demonstrating its innovative reach and the scale of its efforts to prevent heart disease.
Number of employees in the market segment - Heart
iRhythm Technologies has developed a wearable device for long-term heart rate monitoring. The company's success depends on a team of engineers, data analysts, and clinicians. This chart shows the staff growth required to process the growing volume of patient data and expand its commercial presence in the cardiac services market.
Number of employees in the market as a whole
iRhythm Technologies develops wearable devices for heart rate monitoring. The company's growth is driven by innovations in digital health and an aging population. This chart reflects the overall economic situation, but iRhythm shows how technological breakthroughs in medicine are creating entirely new markets and jobs for highly skilled professionals.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company iRhythm Technologies (IRTC)
iRhythm Technologies has developed a wearable heart rate monitoring device. The company's value lies in its unique technology, data analysis algorithms, and patents. This graph demonstrates the high employee value, as a small team of engineers and analysts has created a scalable digital health product.
%20of%20the%20company%20iRhythm%20Technologies%20(IRTC)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-iRhythm-Technologies-IRTC&v=1772578225504 "Chart of market capitalization per employee (in thousands of dollars) of the company iRhythm Technologies (IRTC)")
Market capitalization per employee (in thousands of dollars) in the market segment - Heart
iRhythm Technologies is a digital health company that created Zio, a wearable patch monitor for diagnosing cardiac arrhythmias. It combines a device with a cloud service. This chart shows the average capitalization per employee in the sector. It demonstrates how much the market values their innovative technology and service model per employee.
%20by%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Heart&v=1772578225524 "Market capitalization per employee (in thousands of dollars) by market segment - Heart")
Market capitalization per employee (in thousands of dollars) for the overall market
iRhythm Technologies has developed a wearable device for long-term heart rate monitoring. The company operates at the intersection of medicine and technology, offering a service based on its device. This chart illustrates how investors evaluate a business model where value is created through unique technology, data, and algorithms, rather than a large staff.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772578225665 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company iRhythm Technologies (IRTC)
iRhythm Technologies offers heart rate monitoring solutions (Zio patch). It's a business at the intersection of medicine and data. This graph demonstrates the scalability of their model. Success depends on how many patients a single employee (data analyst or technician) can serve and how effectively the company collects reimbursements from insurance companies for its services.
%20Chart%20iRhythm%20Technologies%20(IRTC)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-iRhythm-Technologies-IRTC&v=1772578225735 "Company Profit Per Employee (in thousands of dollars) Chart iRhythm Technologies (IRTC)")
Profit per employee (in thousands of dollars) in the market segment - Heart
iRhythm is a medtech company producing a wearable patch (Zio) for long-term cardiac monitoring (ECG). This chart shows the benchmark for "Heart" (medtech). In this sector, the benchmark is high, but it depends on reimbursement (Medicare rates). Profit per employee is a balance between R&D, marketing (to physicians), and the price paid by insurance.
%20in%20the%20market%20segment%20-%20Heart&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Heart&v=1772578225739 "Chart of profit per employee (in thousands of dollars) in the market segment - Heart")
Profit per employee (in thousands of dollars) for the market as a whole
iRhythm (IRTC) is a digital health company known for its Zio wearable monitor, which continuously monitors heart rhythm to diagnose arrhythmias. It's a hybrid device and service. This graph, showing average profit per employee, helps us understand how the medtech sector, dependent on R&D and data analysis, outperforms the average labor productivity in the economy.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772578225784 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee iRhythm Technologies (IRTC)
iRhythm Technologies offers wearable heart rate monitoring devices. This chart demonstrates the effectiveness of their business model, which combines a medical device with a data analysis service. The growth in this indicator indicates that more and more doctors trust their technology, and each company employee generates a growing revenue stream.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-iRhythm-Technologies-IRTC&v=1772578225888 "Sales chart per company employee iRhythm Technologies (IRTC)")
Sales per employee in the market segment - Heart
iRhythm Technologies specializes in wearable heart rate monitoring devices. It represents the intersection of MedTech and data analytics services. This chart shows the average revenue per employee in this segment. It helps evaluate how iRhythm's business model, which combines hardware and data analytics, compares favorably to other companies in the cardiac diagnostics field.
Sales per employee for the market as a whole
iRhythm Technologies offers the Zio wearable patch for long-term heart rate monitoring. Their business model combines the device with data analysis. How effectively is the company scaling its platform? This growth means their data analysis technology can handle an increasing number of patients without a corresponding increase in analyst staff.
Short shares by company, segment and market as a whole
Shares shorted by company iRhythm Technologies (IRTC)
iRhythm Technologies specializes in wearable devices (Zio) for long-term heart rate monitoring, helping to detect arrhythmias. This chart shows the number of investors who are skeptical of the business model. They may be betting that competitors will offer better technology or that insurance companies will continue to push reimbursement rates for monitoring services.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-iRhythm-Technologies-IRTC&v=1772578226052 "Short Shares Chart for the Company iRhythm Technologies (IRTC)")
Shares shorted by market segment - Heart
iRhythm Technologies specializes in wearable heart rate monitoring devices. They operate in the competitive digital health space. This indicator summarizes the pessimism in the medical technology sector. It shows whether investors expect problems with reimbursement from insurers or increased competition for the entire industry.
Shares shorted by the overall market
iRhythm (IRTC) produces wearable monitors for arrhythmia diagnostics. This is a growing market in medical technology. However, when the Short_All chart rises, it signals risk aversion. Investors are dumping growth stocks, even in the medical field, and recession fears are causing patients to postpone non-urgent diagnostics, putting pressure on IRTC.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator iRhythm Technologies (IRTC)
iRhythm Technologies produces wearable devices for heart rhythm monitoring (ECG). Business depends on physician adoption and reimbursement rates. This chart shows an IRTC above 70, which may reflect strong patient growth. A range below 30 is often associated with reimbursement issues or competition.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-iRhythm-Technologies-IRTC&v=1772578226164 "RSI 14 indicator chart for the company's stock iRhythm Technologies (IRTC)")
RSI 14 Market Segment - Heart
iRhythm (IRTC) is revolutionizing cardiac diagnostics with its Zio wearable patch, which continuously monitors heart rhythm. These devices replace the old, cumbersome Holter monitors. This graph measures the pulse of the Cardiology Equipment sector. It helps differentiate the success of IRTC's technology from the general "overheating" or "overselling" of the entire medical technology industry.
RSI 14 for the overall market
iRhythm Technologies is a leading provider of wearable devices for long-term heart rhythm monitoring (ECG). Its business is in high-tech healthcare. This chart shows investors' overall risk appetite. During times of panic, growth stocks, even in healthcare, can fall as investors fear a slowdown in the adoption of new technologies.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast IRTC (iRhythm Technologies)
iRhythm Technologies is a digital health company known for its Zio wearable monitor, which tracks heart rhythm over time to detect arrhythmias. This chart summarizes Wall Street forecasts for what they believe is a fair 12-month price for IRTC shares, based on the implementation of their technology.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-IRTC-iRhythm-Technologies&v=1772578226209 "A chart showing analyst consensus forecasts for the expected stock price. IRTC (iRhythm Technologies)")
The difference between the consensus estimate and the actual stock price IRTC (iRhythm Technologies)
iRhythm Technologies is a digital health company. Their flagship product is Zio, a wearable patch for continuous heart rhythm monitoring (ECG) that detects arrhythmia. This chart shows analysts' confidence in their ability to secure insurance reimbursements and replace older Holter monitors. It reflects the gap between the target price and the current price.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-IRTC-iRhythm-Technologies&v=1772578226251 "A chart showing the difference between the consensus forecast and the actual stock price. IRTC (iRhythm Technologies)")
Analyst consensus forecast for stock prices by market segment - Heart
iRhythm (iRTC) is a digital health company known for its wearable "Zio" patch, which continuously monitors heart rhythm to detect arrhythmias. This chart shows analysts' overall expectations for the medical device sector. It reflects whether experts believe the wearable diagnostic device market will grow.
Analysts' consensus forecast for the overall market share price
iRhythm Technologies (IRTC) is the maker of a smart patch (Zio) that monitors heartbeat (arrhythmia) for several days. This graph, reflecting expert expectations, influences them. During a downturn (pessimism), patients may postpone scheduled cardiologist visits, and insurers may be more reluctant to approve new monitoring technologies.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index iRhythm Technologies
iRhythm (IRTC) is a digital medicine company. Their flagship product is Zio, a wearable patch for long-term heart rate monitoring that's more convenient than older Holter monitors. This chart is an indicator of technology adoption. It reflects how quickly doctors and patients are adopting their patches and, crucially, the reimbursement rates (prices) paid by insurers.
AKIMA Market Segment Index - Heart
iRhythm is a pioneer in cardiac diagnostics; the company replaced legacy Holter monitors with its innovative Zio patch, a convenient wearable device for long-term ECG monitoring. This aggregate metric evaluates companies. The chart shows the sector average. This benchmark: how much does iRhythm's technological breakthrough (and its data analytics service model) differentiate it from its average medical tech competitor?
The AKIM Index for the overall market
iRhythm is a MedTech innovator that created the Zio patch, a wearable monitor that replaces bulky ECG machines for diagnosing arrhythmia. This chart, which reflects the market average, is a backdrop. It helps assess how this growth story in the protective healthcare sector compares to the overall macroeconomic trends impacting markets.
